Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2000 Sep;76(899):555–558. doi: 10.1136/pmj.76.899.555

Difficulties in diagnosing and treating depression in the terminally ill cancer patient

M Lloyd-Williams
PMCID: PMC1741750  PMID: 10964119

Abstract

It is estimated that for a quarter of all patients with advanced metastatic cancer, depression will be significant symptom. However up to 80% of the psychological and psychiatric morbidity which develops in cancer patients goes unrecognised and untreated. One of the main difficulties in establishing a diagnosis of an illness where there are no biological markers, physical signs, or diagnostics tests is deciding what can be called "appropriate sadness" as patients approach the end of life and what is a depressive illness.
Criteria for diagnosing depression are discussed together with reasons why established screening tools used in other populations may not be appropriate to screen for depression in terminally ill patients. The use of antidepressants and the role of cognitive therapies are also discussed. For effective treatment of a depressive illness, treatment with antidepressant medication needs to be initiated sooner rather than later and patients may need close supervision to ensure compliance. The awareness of depression, the identification of symptoms, and the initiation of treatment is essential if patients are to be offered optimum palliation of psychological as well as physical symptoms.


Full Text

The Full Text of this article is available as a PDF (83.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brugha T. S. Depression undertreatment: lost cohorts, lost opportunities? Psychol Med. 1995 Jan;25(1):3–6. doi: 10.1017/s0033291700028038. [DOI] [PubMed] [Google Scholar]
  2. Burns M. M., Eisendrath S. J. Dextroamphetamine treatment for depression in terminally ill patients. Psychosomatics. 1994 Jan-Feb;35(1):80–83. doi: 10.1016/S0033-3182(94)71811-9. [DOI] [PubMed] [Google Scholar]
  3. Endicott J. Measurement of depression in patients with cancer. Cancer. 1984 May 15;53(10 Suppl):2243–2249. doi: 10.1002/cncr.1984.53.s10.2243. [DOI] [PubMed] [Google Scholar]
  4. Greer S., Moorey S. Adjuvant psychological therapy for cancer patients. Palliat Med. 1997 May;11(3):240–244. doi: 10.1177/026921639701100309. [DOI] [PubMed] [Google Scholar]
  5. Greer S., Silberfarb P. M. Psychological concomitants of cancer: current state of research. Psychol Med. 1982 Aug;12(3):563–573. doi: 10.1017/s0033291700055665. [DOI] [PubMed] [Google Scholar]
  6. Haig R. A. Management of depression in patients with advanced cancer. Med J Aust. 1992 Apr 6;156(7):499–503. doi: 10.5694/j.1326-5377.1992.tb126481.x. [DOI] [PubMed] [Google Scholar]
  7. House A. Mood disorders in the physically ill--problems of definition and measurement. J Psychosom Res. 1988;32(4-5):345–353. doi: 10.1016/0022-3999(88)90017-7. [DOI] [PubMed] [Google Scholar]
  8. Ibbotson T., Maguire P., Selby P., Priestman T., Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer. 1994;30A(1):37–40. doi: 10.1016/s0959-8049(05)80015-2. [DOI] [PubMed] [Google Scholar]
  9. Linn M. W., Linn B. S., Harris R. Effects of counseling for late stage cancer patients. Cancer. 1982 Mar 1;49(5):1048–1055. doi: 10.1002/1097-0142(19820301)49:5<1048::aid-cncr2820490534>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  10. Lloyd-Williams M., Friedman T., Rudd N. A survey of antidepressant prescribing in the terminally ill. Palliat Med. 1999 May;13(3):243–248. doi: 10.1191/026921699676753309. [DOI] [PubMed] [Google Scholar]
  11. Lynch M. E. The assessment and prevalence of affective disorders in advanced cancer. J Palliat Care. 1995 Spring;11(1):10–18. [PubMed] [Google Scholar]
  12. Maguire P., Faulkner A., Booth K., Elliott C., Hillier V. Helping cancer patients disclose their concerns. Eur J Cancer. 1996 Jan;32A(1):78–81. doi: 10.1016/0959-8049(95)00527-7. [DOI] [PubMed] [Google Scholar]
  13. Maguire P., Hopwood P., Tarrier N., Howell T. Treatment of depression in cancer patients. Acta Psychiatr Scand Suppl. 1985;320:81–84. doi: 10.1111/j.1600-0447.1985.tb08080.x. [DOI] [PubMed] [Google Scholar]
  14. Maguire P. Improving the detection of psychiatric problems in cancer patients. Soc Sci Med. 1985;20(8):819–823. doi: 10.1016/0277-9536(85)90336-3. [DOI] [PubMed] [Google Scholar]
  15. Martin R. M., Hilton S. R., Kerry S. M., Richards N. M. General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants. BMJ. 1997 Mar 1;314(7081):646–651. doi: 10.1136/bmj.314.7081.646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Massie M. J., Holland J. C. Diagnosis and treatment of depression in the cancer patient. J Clin Psychiatry. 1984 Mar;45(3 Pt 2):25–29. [PubMed] [Google Scholar]
  17. Parle M., Jones B., Maguire P. Maladaptive coping and affective disorders among cancer patients. Psychol Med. 1996 Jul;26(4):735–744. doi: 10.1017/s0033291700037752. [DOI] [PubMed] [Google Scholar]
  18. Snaith P. Anhedonia: exclusion from the pleasure dome. BMJ. 1992 Jul 18;305(6846):134–134. doi: 10.1136/bmj.305.6846.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Spiegel D. Cancer and depression. Br J Psychiatry Suppl. 1996 Jun;(30):109–116. [PubMed] [Google Scholar]
  20. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]
  21. de Abajo F. J., Rodríguez L. A., Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ. 1999 Oct 23;319(7217):1106–1109. doi: 10.1136/bmj.319.7217.1106. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES